SUSR.F Stock Overview
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 4/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Surgical Science Sweden AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr13.95 |
52 Week High | kr18.40 |
52 Week Low | kr11.84 |
Beta | 0.93 |
1 Month Change | -2.45% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -0.59% |
Recent News & Updates
Recent updates
Shareholder Returns
SUSR.F | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | -0.3% | 0.3% |
1Y | n/a | -0.6% | 24.2% |
Return vs Industry: Insufficient data to determine how SUSR.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how SUSR.F performed against the US Market.
Price Volatility
SUSR.F volatility | |
---|---|
SUSR.F Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.6% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SUSR.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SUSR.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 260 | Gisli Hennermark | www.surgicalscience.com |
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room.
Surgical Science Sweden AB (publ) Fundamentals Summary
SUSR.F fundamental statistics | |
---|---|
Market cap | US$726.28m |
Earnings (TTM) | US$21.47m |
Revenue (TTM) | US$81.02m |
34.3x
P/E Ratio9.1x
P/S RatioIs SUSR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SUSR.F income statement (TTM) | |
---|---|
Revenue | kr882.85m |
Cost of Revenue | kr269.97m |
Gross Profit | kr612.88m |
Other Expenses | kr378.91m |
Earnings | kr233.97m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
Earnings per share (EPS) | 4.59 |
Gross Margin | 69.42% |
Net Profit Margin | 26.50% |
Debt/Equity Ratio | 0% |
How did SUSR.F perform over the long term?
See historical performance and comparison